News & Updates
Showing Gastroenterology articles
Showing
Show Multimedia Only

OUtMATCH: Omalizumab gains FDA nod for IgE-mediated food allergies
05 Mar 2024
byAudrey Abella
Omalizumab scores in the NIH*-sponsored phase III OUtMATCH** trial, increasing the threshold for an allergic reaction to peanut and other common food allergens in children and adults with multiple food allergies.
05 Mar 2024

Nivolumab plus ipilimumab superior to sunitinib in advanced RCC
01 Mar 2024
byStephen Padilla
First-line treatment with nivolumab plus ipilimumab (NIVO+IPI) results in better survival and response benefits in patients with advanced renal cell carcinoma (aRCC) when compared with sunitinib (SUN), as shown by long-term follow-up data from the CheckMate 214 trial.
01 Mar 2024






